COMMUNIQUÉS West-GlobeNewswire

Profusa Shareholders Approve Strategic Initiatives at 2026 Annual Meeting, Supporting PanOmics Acquisition, Balance Sheet Strengthening and Nasdaq Compliance Efforts
24/06/2026
BERKELEY, Calif., June 24, 2026 (GLOBE NEWSWIRE) -- Profusa, Inc. (Nasdaq: PFSA), a digital health company pioneering next-generation biosensing technologies, announces that shareholders approved all proposals presented [...]
Bionano Announces Hiring of Chief Scientific Officer
24/06/2026
SAN DIEGO, June 24, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO), a leader in genome analysis solutions, today announced the appointment of Alex Hastie, Ph.D. , as its Chief Scientific Officer (CSO) , [...]
LENZ Therapeutics and Arrotex Pharmaceuticals Announce Exclusive License and Commercialization Agreement for VIZZ™ in Australia and New Zealand
24/06/2026
Exclusive license and commercialization agreement includes a significant profit share of gross margin from product sales in addition to an upfront license payment to LENZ SAN DIEGO and MELBOURNE, Australia, June 24, [...]
Helus Pharma Provides Update on APPROACH Phase 3 Trial Enrollment Progress
24/06/2026
- APPROACH Phase 3 clinical trial of HLP003 for the adjunctive treatment of major depressive disorder (“MDD”) is progressing as planned and has surpassed 86% enrollment - - Phase 2 HLP003 data demonstrated long-term [...]
Next-Generation DNA Repair Inhibitors Could Capture Billions in Emerging Market
24/06/2026
AUSTIN, Texas, June 24, 2026 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage : Oncology research is moving through one of its most active stretches in years. DNA Damage Response (“DDR”) inhibitors, a category of drugs [...]
Enlivex Treasury Portfolio Update: Listing of the RAIN Token on Gate, One of the World's Largest Cryptocurrency Exchanges by Spot Trading Volume
24/06/2026
Ranked second globally in 24-hour spot trading volume, Gate further extends market access and secondary liquidity for Enlivex ’ s primary digital treasury asset Nes-Ziona, Israel, June 24, 2026 (GLOBE NEWSWIRE) -- [...]
Onconetix Highlights Realbotix’s Launch of Humanoid Robot and AI Teachers Assistant Pilot Program in New York State School District
24/06/2026
Salamanca City Central School District on Seneca Nation Reservation to Deploy Optio and Realbotix M-Series Humanoid Robot; Pilot to Expand to Approximately 500 High School Students in Fall 2026; Onconetix Recently [...]
EchoIQ Strengthens Leadership Team and Clinical Advisory Network to Accelerate Next Phase of Commercial Growth and U.S. FDA Initiatives
24/06/2026
Matthew Dodds appointed Chief Financial Officer, bringing over 30 years of healthcare, medical technology, capital markets, corporate development and investor relations experience Dr. Vinod Thourani appointed Clinical [...]
Wave Life Sciences Announces Initiation of Phase 2a Portion of INLIGHT™ Trial of WVE-007 (INHBE GalNAc-siRNA) for Obesity and Cardiometabolic Diseases
24/06/2026
In Phase 1 portion of trial, WVE-007 improved body composition by inducing fat loss, including harmful visceral fat, while maintaining muscle; data continue to support once or twice-yearly dosing Phase 2a portion in [...]
Picard Medical Announces Leadership Transition
24/06/2026
Chairman, Richard Fang Appointed Interim Chief Executive Officer TUCSON, Ariz., June 24, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (“Picard Medical” or the “Company”), parent company of [...]
Noom Members Regained 3x Less Weight After Stopping GLP-1s vs Standard-of-Care, New Analyses Show
24/06/2026
In two analyses, Noom members were modeled to gain less than 2% of bodyweight up to 12 months after stopping medication — with the strongest maintenance among those who continued practicing healthy habits Noom members [...]
BrewDog and Tilray Beer Are Ready to Pour the World’s Biggest Bar Tab — £1 Million of Free Pints
24/06/2026
Jersey on. Crew ready. If England, Scotland or the U.S. reaches the final, fans can head straight to participating BrewDog pubs 1 and Tilray-owned brewpubs 2 across the U.S. to claim up to two free pints before the £1 [...]
NeOnc Ignites Explosive Summer: 4 New Research Reports + UAE/Dubai Drug Approval Fuel Breakout Momentum
24/06/2026
NTHI Continues to Build Regulatory Momentum prior to Upcoming Phase 2 Data DENVER, June 24, 2026 (GLOBE NEWSWIRE) -- ( 247marketnews.com ) -- NeOnc Technologies Holdings (NASDAQ: NTHI) is entering one of the most [...]
Calidi Biotherapeutics Presents New Data on CLD-501, Its In Situ T-Cell Engager Candidate Targeting TROP-2 at the T-Cell Engager Therapeutic Summit
24/06/2026
Findings highlight RedTail’s potential to overcome historical limitations of T-cell engagers in solid tumors through tumor-specific, localized expression SAN DIEGO, June 24, 2026 (GLOBE NEWSWIRE) -- Calidi [...]
Respiree Appoints Patty Riskind as Chair of the Board of Directors
24/06/2026
HOUSTON and SINGAPORE, June 24, 2026 (GLOBE NEWSWIRE) -- Respiree, a leading AI-driven healthcare company advancing predictive cardiorespiratory monitoring and proactive care, announced today the appointment of Patty [...]
Cadrenal Therapeutics Announces Selection of CAD-1005 Phase 2 Study for Late-Breaking Oral Presentation at ISTH 2026 Congress
24/06/2026
Selection highlights the clinical value potential of Cadrenal’s first-in-class 12-lipoxygenase inhibitor for Heparin-Induced Thrombocytopenia (HIT) First-ever randomized, blinded, placebo-controlled trial in HIT, a life [...]
The Quest to Repair What Multiple Sclerosis Takes Away
24/06/2026
AUSTIN, Texas, June 24, 2026 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage : Multiple sclerosis (“MS”) gradually strips people of command over their own bodies, advancing steadily with no available cure. More than 2 [...]
Response Biomedical Expands Global Diagnostics Portfolio with the Launch of the RAMP Xpress
24/06/2026
Expands Response Biomedical beyond acute care into chronic disease and wellness testing Introduces a next-generation platform for metabolic and inflammatory biomarker testing Combines speed, portability, and workflow [...]
AIM ImmunoTech Accelerates Toward Potential Pivotal Pancreatic Cancer Program as Ampligen Continues to Advance Through Key Clinical Milestones
24/06/2026
Recent Clinical Progress, Enrollment Achievements, Expanded Intellectual Property Portfolio and Strengthened Financial Position Support a Potentially Transformative 12-Month Value Creation Opportunity OCALA, Fla., June [...]

Pages